Reliance Retail acquires Netmeds ownership for ₹620 crore

More From Author

See more articles

5 Easy Ways to Download Free MP3 Songs for...

Looking to expand your music library without spending a fortune? Look no further! In this article, we...

Mivi DuoPods i7 Review: Things need to know before...

The wearable industry in India is still exciting and keeps on growing. Driven by price-sensitive consumers, the...

Top 10 Best Smartwatches under 2000 INR in November...

With the growing focus on fitness and health, a smartwatch has become an essential companion for tracking...

Reliance Retail Venture Limited (RRVL), fully owned by Reliance Industries Limited acquires majority stakes of the Chennai-based online pharmacy platform Vitalic Health Pvt. Ltd. and its subsidiaries, together commonly known as Netmeds.

Reliance spends Rs. 620 crores in cash for it and bagged 60% equity share of the main company Vitalic Health Pvt. Ltd., along with 100% ownership of the subsidiaries that include  Tresara Health Private Limited, Netmeds Market Place Limited and Dadha Pharma Distribution Pvt Limited.

The Director of RRVL, Isha Ambani said that this move will enhance the company’s health care and product service and that’s also at affordable prices. She added, “This investment is aligned with our commitment to provide digital access for everyone in India,”

Reliance Industries Limited becomes debt-free with Jio's overwhelming investments & Rights Issue

“We are impressed by Netmeds’ journey to build a nationwide digital franchise in such a short time and are confident of accelerating it with our investment and partnership,” – Isha.

The Founder and CEO of Netmeds, Pradeep Dadha said, “With the combined strength of the Reliance’s digital, retail and tech platforms, we will strive to create more value for everyone in the ecosystem, while providing a superior Omni Channel experience to consumers.”

A few days earlier, Amazon India started its online drug store named “Amazon Pharmacy” in Bangalore. It already partnered with Giant Eagle Pharmacy, a US-based company in November.

An EY report said, the e-pharmacy market valued $9.3 billion in 2019 and can reach up to $18.1 billion by the next four years (by 2023) with an 18.1% compounded annual growth rate.

Source

Do Check Out 👇🏼

TechnoSports 🔥 Stay Updated

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

━ Related News

Featured

━ Latest News

Featured